Table 1.
Summary of clinical cases reporting the use of ascorbate in G6PDdef.
| Hemolytic Trigger |
Dose | Treatment | Dose | Response to Trigger | Type of Study | References | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ascorbate | 80g/day, IV | Blood transfusion | X | X | X | X | X | case study | [118] | ||
| Ascorbate | 40g/3x/week, IV + 20-40g/daily/oral | X | X | X | case study | [119] | |||||
| Increased to 80g/3x/week, IV | |||||||||||
| Ascorbate | 30g/day, IV | Blood transfusion | 8 days | X | X | case study | [120] | ||||
| 60g/day, IV | |||||||||||
| Fava Beans Ascorbate | ~10 beans | X | case study | [121] | |||||||
| 250-500mg/day, oral | |||||||||||
| Ascorbate | 4-6g/6hr, oral | Blood transfusion | X | X | case study | [122] | |||||
| Ascorbate | 30g/day, IV | Blood transfusion | X | X | X | X | case study | [123] | |||
| Ascorbate | 75g/day, IV | Blood transfusion | X | X | X | X | case study | [124] | |||
| Ascorbate | 2g/day, IV | - | X | X | case study | [125] | |||||
| Rasburicase | 6mg | Ascorbate | 5g/6hrs, IV | X | X | X | case study | [46] | |||
| Blood transfusion | |||||||||||
| Rasburicase | 6mg | Ascorbate | 1g/day, oral | X | X | X | case study | [47] | |||
| Blood transfusion | |||||||||||
| Chloroquine + Covid-19 | 600mg/day | Ascorbate | 1g/4x/day | X | X | case study | [23] | ||||
| Blood transfusion | |||||||||||
| Fava Beans Ciprofloxacin Acetaminophen | 500mg/2x/daily 1000mg/3x/daily |
Ascorbate | 1g/4x/day | X | X | X | X | case study | [48] | ||
| Blood transfusion | |||||||||||
| Hemolysis/Anemia | Dark Urine | Methemoglobinemia | Respiratory Distress /↓O2 | Death | Renal Failure | ||||||